Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY · NASDAQ Global Market
-$0.61 today
Vol 0.65M · Avg 0.82M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+4.23%
Period High
$40.51
Period Low
$25.90
Latest
$33.28
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.53B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.20B
Aurinia Pharmaceuticals Inc.
NASDAQ:AUPH
$2.09B
Nuvation Bio Inc.
NYSE:NUVB
$1.87B
Sionna Therapeutics, Inc.
NASDAQ:SION
$1.69B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.66B
Immunocore Holdings plc
NASDAQ:IMCR
$1.47B
Biohaven Ltd.
NYSE:BHVN
$1.42B
MannKind Corporation
NASDAQ:MNKD
$1.21B
Janux Therapeutics, Inc.
NASDAQ:JANX
$852.56M
What is the latest HRMY filing?
The latest filing shown is 4 dated May 18, 2026.
How many recent filings does HRMY have?
Intrinsic Alpha currently shows 20 recent filings for HRMY.
Explore More
Continue the stock analysis
Jump to another research area for this company.